New criteria for Alzheimer's disease: Which, when and why?

Jonathan M. Schott; Ronald C. Petersen

doi:10.1093/brain/awv055

New criteria for Alzheimer's disease: Which, when and why?

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1134-1137
Number of pages	4
Journal	Brain
Volume	138
Issue number	5
DOIs	https://doi.org/10.1093/brain/awv055
State	Published - May 1 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1093/brain/awv055

Cite this

@article{406f3da7461845f2a6028c82360df099,

title = "New criteria for Alzheimer's disease: Which, when and why?",

author = "Schott, {Jonathan M.} and Petersen, {Ronald C.}",

note = "Funding Information: J.M.S. acknowledges the support of Alzheimer{\textquoteright}s Research UK, the NIHR Queen Square Dementia Biomedical Research Unit, UCL/H Biomedical Research Centre, and Leonard Wolfson Experimental Neurology Centre. R.C.P. receives support from the National Institute on Ageing of the National Institutes of Health and the Mayo Clinic and serves in a consulting capacity for Pfizer, Inc., Janssen Alzheimer Immunotherapy, Roche, Inc., Merck, Inc. and Genentech, Inc.",

year = "2015",

month = may,

day = "1",

doi = "10.1093/brain/awv055",

language = "English (US)",

volume = "138",

pages = "1134--1137",

journal = "Brain",

issn = "0006-8950",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - New criteria for Alzheimer's disease

T2 - Which, when and why?

AU - Schott, Jonathan M.

AU - Petersen, Ronald C.

N1 - Funding Information: J.M.S. acknowledges the support of Alzheimer’s Research UK, the NIHR Queen Square Dementia Biomedical Research Unit, UCL/H Biomedical Research Centre, and Leonard Wolfson Experimental Neurology Centre. R.C.P. receives support from the National Institute on Ageing of the National Institutes of Health and the Mayo Clinic and serves in a consulting capacity for Pfizer, Inc., Janssen Alzheimer Immunotherapy, Roche, Inc., Merck, Inc. and Genentech, Inc.

PY - 2015/5/1

Y1 - 2015/5/1

UR - http://www.scopus.com/inward/record.url?scp=84929657474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929657474&partnerID=8YFLogxK

U2 - 10.1093/brain/awv055

DO - 10.1093/brain/awv055

M3 - Article

C2 - 25907755

AN - SCOPUS:84929657474

SN - 0006-8950

VL - 138

SP - 1134

EP - 1137

JO - Brain

JF - Brain

IS - 5

ER -

New criteria for Alzheimer's disease: Which, when and why?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this